hepatitis C (HCV)
To Tell the Truth: Applicant Nondisclosure of Obesity and HIV and Hepatitis C
Applicants’ self-disclosed Human Immunodeficiency Virus (HIV) and hepatitis C virus (HCV) status as well as body mass index (BMI) are important risk factors for morbidity and mortality in both accelerated and traditional (full) underwriting processes. In combination with self-disclosed smoking and medical history (diabetes, hypertension, heart failure, high cholesterol), which was discussed in a previous issue of Contingencies, these conditions constitute a majority of the leading medical inputs to the risk-assessment process.
Are you Seeing These 6 Trends Changing the Life Insurance Risk Landscape?
Our recent conversations with insurance partners highlight six prevalent risks at the top of mind for industry leaders today.
HIV and Hepatitis C and B Coinfetions
Around 36 million people are living with HIV in the world today (LVWH). 5 million of them are also infected with the hepatitis C virus (HCV) and 4 million with hepatitis B virus (HBV). In both cases, HIV and the immunodeficiency it causes, accelerate the progression of hepatitis B or C, inducing increased morbidity and mortality for all three infections.
RGA ReFlections Fall 2015 Issue
A redesigned ReFlections highlights insights from RGA Vice President and Medical Director Dr. Daniel D. Zimmerman into the 'new frontier' of hepatitis C. Mark Dion, RGA Vice President, Global Underwriting Strategic Innovation, explores the quantified self movement. A new column, ReCite, links to medical articles for insurance professionals, and the edition features a report on mortality and longevity research funded by The Longer Life Foundation, which is supported by RGA and Washington University School of Medicine in St. Louis.